The global atherectomy devices market is projected to grow from USD 1.04 billion in 2025 to USD 1.51 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 7.69% during the forecast period.
This growth is driven by the increasing prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD), advancements in minimally invasive surgical techniques, and technological innovations in atherectomy devices.
Get a Sample PDF copy of the report @ https://www.reportsinsights.com/sample/664624
Atherectomy devices are specialized medical instruments designed to remove atherosclerotic plaque from blood vessels, thereby restoring blood flow in patients with conditions such as PAD and CAD. These devices employ various mechanisms, including directional, rotational, orbital, and laser technologies, to excise or reduce plaque buildup without the need for major surgery.
Rising Prevalence of Cardiovascular Diseases: The increasing incidence of PAD and CAD, particularly among the aging population, is a significant driver for the atherectomy devices market. Factors such as sedentary lifestyles, unhealthy diets, and rising rates of diabetes and obesity contribute to the growing burden of these diseases.
grandviewresearch.com
Advancements in Minimally Invasive Procedures: There is a growing preference for minimally invasive surgeries due to their benefits, including reduced trauma, shorter recovery times, and lower risk of complications. Atherectomy procedures align with this trend, offering effective treatment options with improved patient outcomes.
mordorintelligence.com
Technological Innovations: Continuous product development and commercialization are propelling market growth. For instance, the introduction of advanced laser atherectomy systems enhances procedural precision and safety, encouraging broader adoption among healthcare providers.
mordorintelligence.com
Despite the positive outlook, the market faces challenges such as stringent regulatory scenarios, which may restrain growth over the forecast period.
By Product Type:
Directional Atherectomy Devices: These devices held the largest market share in 2022, owing to their capability of collecting shaved plaque, which reduces the risk of barotrauma and other complications.
grandviewresearch.com
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices: Expected to be the fastest-growing segment, laser atherectomy offers more precision in plaque removal and causes fewer complications.
grandviewresearch.com
By Application:
Peripheral Vascular Applications
Cardiovascular Applications
Neurovascular Applications
By End User:
Hospitals and Surgical Centers
Ambulatory Care Centers
Other End Users
North America: Held the largest market share in 2022, driven by a high prevalence of PAD and favorable reimbursement policies.
grandviewresearch.com
Europe: Significant market due to advanced healthcare infrastructure and increasing adoption of minimally invasive procedures.
Asia-Pacific: Anticipated to observe the fastest growth, attributed to improving economic conditions, increasing prevalence of lifestyle diseases, and expanding healthcare infrastructure.
grandviewresearch.com
Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://www.reportsinsights.com/industry-forecast/atherectomy-devices-market-statistical-analysis-664624
The atherectomy devices market is competitive, with key players focusing on technological advancements and strategic collaborations to strengthen their market position. Some of the major companies operating in the market include:
Boston Scientific Corporation
Cardiovascular Systems, Inc.
Medtronic
Avinger
Koninklijke Philips N.V.
BD (Becton, Dickinson and Company)
Abbott
Terumo Corporation
The atherectomy devices market is poised for significant growth through 2032, driven by the rising prevalence of cardiovascular diseases, technological innovations, and an increasing preference for minimally invasive procedures. However, market participants must navigate challenges such as stringent regulatory environments and the need for continuous product development to maintain a competitive edge.
Note: The projected CAGR of 7.69% is based on data from 2025 to 2030. For the period extending to 2032, further analysis would be required to provide an updated CAGR.